WARREN, N.J. —  GSK Consumer Healthcare announced a new innovation for Theraflu cold and flu symptom relief with the U.S. launch of Theraflu PowerPods Severe Cold. The brand recognizes consumer’s ever-changing lifestyles and, through this expansion of the current Theraflu portfolio, is modernizing how consumers can achieve cold & flu symptom relief. Compatible with single-serve coffee machines, Theraflu PowerPods brew a cup of warm, soothing relief with the press of a button.

“At GSK, we continuously challenge ourselves to provide Theraflu consumers with new ways to ‘do sick differently’,” said Latisha Tillie, senior brand manager of Theraflu. “Our goal with the launch of PowerPods is to expand cold and flu remedies beyond the medicine cabinet and into the center of everyday wellness – the kitchen.”

Additionally, Theraflu is declaring this week, the week of October 1, 2018, the first week of cold and flu season. This is when the incidence of influenza-like illness is predicted to start the seasonal rise. This week was determined by comparing historic CDC incident data, Sickweather social sentiment regarding illness symptoms and US sales of Theraflu cold and flu symptom relief products.

Users can check out the Cold & Flu Tracker, created with The Weather Channel and using data from Sickweather. The tracker provides real-time, local level updates on the severity of the cold & flu season across the country and is available on www.theraflu.com, www.weather.com and The Weather Channel App.

Theraflu PowerPods are available online and at major retail stores nationwide in Daytime and Nighttime formulas. Theraflu also offers cold & flu symptom relief in syrup, caplet and hot liquid powder formulas.